Pasithea Therapeutics Corp. (KTTAW) has a market capitalization of $110.89K and trades at $0.01. The 52-week range is 0.0083-0.0181.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-2.91.
The stock has a beta of 1.91, operates in the Healthcare sector.
